Most Favored Patient

Why are liberals siding with/apologizing to big health insurers after spiking premiums, deductibles & copays for years? Because their profit & political goals are tied together and b/c @realDonaldTrump & @GOP are now reining them in. @kerpen @SpeakerJohnson

It's time for Germany and Japan to pay their fair share for U.S. medical innovation. @POTUS "Both governments appear to be betting that the United States is unwilling to impose meaningful trade consequences for discriminatory pricing practices. The Trump administration already proved Germany wrong—and should do so in Japan. A Section 301 investigation is the right tool." Read more in @Newsweek: newsweek.com/stop-germany-j…

Thank you, @POTUS, for standing up for American patients and taking action to stop foreign freeloading off U.S. medical innovation. This is exactly the kind of free-market solution that MFP advocates for. @SteveForbesCEO @StephenMoore @kerpen cnbc.com/2026/06/19/us-…

.@SteveForbesCEO is spot on. Patients want lower-cost health care. It's time for the U.S. to take patient access and affordability seriously. Price controls are not the solution. @WSJopinion

Basically, big PBMs—owned by big insurers—are suing IL to avoid disclosing what plans (insurers) pay PBMs (insurer subsidiaries), how much PBMs pay pharmacies, and the size of rebates (40-60%+) PBMs got/pocketed from the drugmaker (vs. passing on to the patient). @RebeccaMPifer @kerpen @mcuban

Surely, @AARPIllinois will oppose this and not remain quiet because @AARP was paid over $10 BILLION via insurer-PBM giant UnitedHealth (now under DOJ criminal investigation) – right? Don’t count on it. @kerpen @CitizenActionIL @lschencker @RebeccaMPifer healthcaredive.com/news/pcma-sues…

.@kerpen and @StephenMoore: "To be clear, we don’t think a price control system can be made beneficial, or even benign. We support policies that would encourage more new cures and treatments while lowering costs to patients." This is the way forward. @MikeCrapo @SenFinance @WhiteHouse washingtonexaminer.com/op-eds/4609653…

Foreign freeloading off U.S. medical innovation harms R&D and leaves American patients footing the bill. The free market solution? "Pursue more agreements like President Trump’s recent deal with the United Kingdom, in which the UK committed to paying more for innovative medicines. If other wealthy countries like Japan and Germany agree to do the same, it would both strengthen the financial foundation of U.S. biotech and allow domestic prices to fall." Read more in @BreitbartNews 👇 breitbart.com/politics/2026/…

The Biden-era IRA "undermines the return on the multi-billion-dollar investment required to develop a new drug and bring it to market, resulting in fewer new cures and treatments." @SenFinance @MikeCrapo Learn how @POTUS can right the ship in this new @dcexaminer piece from @StephenMoore and @kerpen: washingtonexaminer.com/op-eds/4609653…

Critical from @stephenmoore and @kerpen The Inflation Reduction Act was a disaster - but the Biden teams implementation found a way to make it even more destructive. CMS can start countering damage by removing the Biden policy and personnel still carrying out the Biden vision.

.@RepMGriffith: "Increased transparency is also critical to bringing health care disruptors into the marketplace and promoting competition amongst insurers and providers, where we continue to see consolidation that contributes to higher health care costs.” This is spot on. Lowering health care costs means stopping big insurers from using opaque practices to profit at patients' expense. @HouseCommerce @RepGuthrie @SteveForbesCEO @realdocspeaks energycommerce.house.gov/events/health-…

Thank you, @RepGuthrie & @RepMGriffith, for holding today's @HouseCommerce hearing on increasing transparency in the health care system. Transparency is the third prong of MFP's ACT plan, a patient-first roadmap with specific policies to hold insurers accountable and lower costs for everyday Americans. Learn more here: mostfavoredpatient.org/act-plan @RepHarshbarger @StephenMoore energycommerce.house.gov/events/health-…

Today's @HouseCommerce hearing on increasing health care transparency is the perfect opportunity to discuss patient-first reforms that bring much-needed transparency to big insurer-PBMs. @RepGuthrie @RepMGriffith @RepHarshbarger, it's time to stop these conglomerates from gaming the system at Americans' expense. @kerpen energycommerce.house.gov/events/health-…

Most Favored Nation drug pricing will devastate our biopharmaceutical sector and keep health care costs high. We urge lawmakers to REJECT the codification of MFN to protect patients and American innovation. @berniemoreno @HawleyMO foxnews.com/opinion/stephe…

STEPHEN MOORE: Foreign price controls on medicine are nothing but a hidden tax on American families. It’s time to stop forcing American patients to subsidize the rest of the world's healthcare.

NEW: Op-ed from MFP co-founder @StephenMoore on why America can't keep funding the world's drug innovation alone. "For decades, the United States has been a leader in drug innovation, improving lives for millions of people throughout the world. But there’s no guarantee this will continue. And it might not if U.S. companies are forced to subsidize innovation." We're calling on lawmakers: understand the consequences. MFN would gut the incentives that drive R&D, placing the burden on American patients. Reject MFN in reconciliation. @SenSusanCollins @lisamurkowski foxnews.com/opinion/stephe…

Foreign price controls like Most Favored Nation will NOT lower health care costs for American patients. It's a short-term fix that sacrifices tomorrow's cures for today's savings. We urge lawmakers to reject the proposed MFN provisions in reconciliation and put patients first. @SenatorCollins @lisamurkowski @SenMcCormickPA @SenHawleyPress @SenDanSullivan @berniemoreno @SenJonHusted

Big insurers are pointing fingers, but the real culprit is staring at them in the mirror. In a new op-ed, MFP co-founder @kerpen makes the case to lawmakers: stop letting insurance conglomerates off the hook and start putting patients first. @StephenMoore @WSJOpinion cagle.com/columnist/phil…

NEW: MFP co-founder, @kerpen, exposes the perverse practices of big insurance cartels that keep American health care costs high. "Congress cannot go another year without major health care reform. Members of Congress face a simple choice: stand with families and win, or bow down to Big Insurance and face the wrath of an electorate that has finally had enough." @RepJasonSmith @wendellpotter Read more. cagle.com/columnist/phil…

.@US_FDA takes a decade to approve products already proven safe and effective. A new study from MFP co-founder Tomas Phillipson highlights how cutting just one year off that process would unlock $10 trillion. China's approval process is 50-70% faster than ours. It's time for a shake-up. @kerpen @WSJOpinion wsj.com/opinion/the-fd…